Business Context and Reporting Period
This Form 8-K Current Report from Omeros Corporation (OMER) covers events occurring on June 11, 2021, specifically the Company's 2021 Annual Meeting of Shareholders. The filing details the election of directors, the ratification of the independent auditor, and the approval of an amendment to the Company's equity incentive plan.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
- Shareholder Participation: Of 62,325,125 shares entitled to vote, 46,071,587 shares (73.9%) were represented at the meeting.
- Director Elections:
- Thomas F. Bumol, Ph.D.: Elected (27,554,017 For; 2,718,868 Against).
- Gregory A. Demopulos, M.D.: Elected (28,280,206 For; 1,857,471 Against).
- Leroy E. Hood, M.D., Ph.D.: Elected (19,966,295 For; 10,307,337 Against).
- Compensation Plan Amendment: Shareholders approved an amendment to the 2017 Omnibus Incentive Compensation Plan, increasing the aggregate number of authorized shares by 4,000,000 to a total of 12,600,000 shares. The vote was 22,621,598 For versus 7,543,739 Against.
- Auditor Ratification: Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2021, with 44,784,520 votes For and 1,141,578 Against.
Guidance, Outlook, and Risks
The filing does not contain management commentary on business outlook, financial guidance, or specific risk factors. It strictly reports on the outcomes of shareholder votes and corporate governance actions.
Key Facts for Investor Verification
- Verify the dilution impact of the 4,000,000 share increase in the Omnibus Incentive Compensation Plan.
- Note the significant "Against" vote (approx. 34%) for the election of Director Leroy E. Hood compared to the other nominees.
- Confirm the total authorized share count under the amended plan is now 12,600,000 shares.
- Review the definitive proxy statement filed on April 30, 2021, for full details on the amended compensation plan terms.